Go back to News
NEWS
Íñigo Erláiz new Managing Partner
The General Meeting of Partners of Gómez-Acebo & Pombo has approved this Monday, January 31, the appointment of Íñigo Erláiz as new Managing Partner.Íñigo Erláiz replaces Carlos Rueda, who will become Chairman of the Board of Directors of the Firm. The change at the head of the Firm’s management is part of an internal process resulting from the limitation of terms in the position of Managing Partner under the Firm’s bylaws.
The Meeting has also agreed to the renewal of the Board of Directors, which will be formed from now on by: Íñigo Erláiz, Miguel Lamo de Espinosa, Daniel Marín, Álvaro Mateo, Manuel Martín, Verónica Romaní, Mónica Weimann and Carlos Rueda as Chairman.
Íñigo Erláiz thanks the partners of the Firm for their support and trust and mentions his “enthusiasm to take on this project and contribute as much as possible, with the support of all the partners, to continue promoting the Firm as an Iberian firm of reference and thus continue with the upward trend of recent years”.
Experience
Íñigo Erláiz joined Gómez-Acebo & Pombo in 1999, where he has developed his entire professional career and where he has been a partner since 2010. He has headed the Corporate area since 2016, a period in which said practice has experienced remarkable growth, and is a specialist in M&A having regularly advised on mergers and acquisitions and private equity transactions. Íñigo Erláiz has been a member of the Firm’s Board of Directors for the last eight years.
He holds a degree in Law and a diploma in Corporate Legal Consultancy, with honors, from the Universidad Pontificia de Comillas (ICADE). He has a Master’s Degree in Human Resources Management from the UNED. He holds a diploma in Bankruptcy Law from the Madrid Bar Association.
Expansión
El Confidencial
El Economista
Cinco Días
Iberian Lawyer
Lawyer mentioned
Iñigo Erlaiz – Partner
Press contact
Sandra Cuesta
Director of Business Development, Marketing and Communications
Sandra Cuesta
Director of Business Development, Marketing and Communications
More information about
Gómez-Acebo & Pombo
PUBLICATION
¡NEW!
On the exclusion of “financial instruments” from consumer protection provisions for the purposes of applicable law
For the purposes of Article 6 of Rome I, the provisions of a contract defining the terms on which a professional receives or executes a CFD-related order are not covered by the exception provided for in Article 6(4)(d).
PUBLICATION
2 days ago
Omnibus VIII package to simplify environmental legislation: measures regarding industrial emissions and environmental impact assessments
The 8th Omnibus Package aims to simplify environmental legislation in order to reduce administrative burdens on businesses. This paper outlines the proposed measures and examines, in particular, the proposed amendments to the Industrial and Livestock Rearing Emissions Directive, as well as the proposal for a regulation on speeding-up environmental assessments.
PUBLICATION
3 days ago
Public policy considerations in the recognition of foreign arbitral awards settling consumer disputes
Judicial review may extend to the substantive invalidity of the arbitration agreement because it conflicts with mandatory domestic rules — as well as those of the European Union — on consumer protection and, consequently, the concept of public policy encompasses both procedural and substantive public policy.
PUBLICATION
26 Jun, 2026
Limitation period, extinguishment period, ADR, time window, limitation period, extinguishment period, ADR (a)
Article 7 of Act 1/2025 contains two references to time limits which appear to set out two different rules regarding limitation periods. However, Article 7(3) is not a rule on limitation periods.
PUBLICATION
24 Jun, 2026
Invalidity, due to shareholder oppression, of the resolution to file a director liability (to company) claim
The Supreme Court (Judgment no. 824/2026, dated 29 May) affirmed the declaration of invalidity of a company resolution to file a director liability (to company) claim, finding that it had been abusively imposed by the majority insofar as not responding to a reasonable need of the company and having been passed by the majority in its own interest and to the unjustified detriment of the minority.
PUBLICATION
23 Jun, 2026
Pharma & Healthcare No. 49
The newsletter covers the main developments in Pharma & Healthcare legislation and case law.
PUBLICATION
18 Jun, 2026
An insurer may be sued by way of a direct action under Spanish law even if the law governing the insurance contract does not allow such an action
The Supreme Court clarifies the rules governing direct actions in international cases and the limits of the law governing insurance contracts
PUBLICATION
18 Jun, 2026
Royal Decree 415/2026: key aspects of the new health technology assessment system
Royal Decree 415/2026 establishes a unified framework for the assessment of health technologies in Spain, distinguishing between the technical assessment and the administrative decision regarding funding, pricing or inclusion in the service catalogue, and incorporating the requirements of Regulation (EU) 2021/2282. The aspect that raises the most legal questions in this new piece of legislation is the connection between the assessment regulated by the Royal Decree and the procedures for funding, pricing, and inclusion in the service catalogue.
PUBLICATION
15 Jun, 2026
Conclusions on the abuse of temporary public sector employment: finding a balance between domestic laws and EU law